Deal Type

US-based Cactus Life Sciences, a global scientific communications agency that works with pharma and biotech companies, has acquired nspm and eluSCIdate, two medical communications...

LabConnect, a partner to pharmaceutical and biotechnology companies, CROs, and NGOs to accelerate the development of new medicines, has acquired UK-based A4P Consulting, a...

PE firms, Foundation Partners and Deer Capital, have announced plans to acquire care home provider, Hartford Care, for over £100m (US$125m). The transaction represents...

Kühne Holding, has entered into a definitive agreement to acquire pharma contract development and manufacturing organization Aenova Group from leading international investment firm London-based...

TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and Singapore, has invested €16m (US$17m) in Munich-headquartered neurocare group, a personalized mental health care provider. Through...

TT medic, an Austria-headquartered medtech development and manufacturing partner for high-quality polymer components, has entered a partnership with Sweden-based Trill Impact to accelerate growth....

KKR is acquiring Immedica Pharma, a pharmaceutical company headquartered in Stockholm. Existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside...

DocMorris, a Swiss online pharmacy and pharma wholesaling group formerly known as Zur Rose, has issued a CHF200m (US$219m) five-year senior unsecured convertible bonds...

Medartis Holding, a SIX-listed specialized orthopaedic company for head and extremity surgery, has placed CHF115.8m (US$127m) senior unsecured guaranteed convertible bonds due April 11,...

Pharming Group, a global biopharmaceutical company, has launched approximately €100m (US$107m) senior unsecured convertible bonds due 2029 and concurrently invited current holders of its outstanding...